Picture loading failed.

Anti-PCSK9 therapeutic antibody (Pre-made Evolocumab biosimilar,Whole mAb) is a biosimilar expressed by mammalian cell line as a benchmark reference therapeutic antibody for biological drug disovery items including cell culture, assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic) and mechanism of action (MOA) research.

Evolocumab (trade name Repatha) is a monoclonal antibody medication designed for the treatment of hyperlipidemia.

Order information

Delivery impact due to the Coronavirus Outbreak

With the COVID-19 outbreak in the world, many flights have been cancelled. In order for the customer to receive the goods properly, we use the FedEx Customized Freight (FCF) of Fedex which demands a higher fee. If the delivery fee is more expensive in your area, we will contact you by mail.

Catalog No. Package Price(In USD) Qty (Quantity) Sum(In USD)
GMP-Bios-ab-202-1mg 1mg 3090
GMP-Bios-ab-202-10mg 10mg 21890
GMP-Bios-ab-202-100mg 100mg 148000
GMP-Bios-ab-202-xmg ≥100mg Inquiry
Shipping Cost: 760.00


Products Name (INN Index) Anti-PCSK9 therapeutic antibody (Pre-made Evolocumab biosimilar,Whole mAb)
INN Name Evolocumab
FormatWhole mAb
Species ReactivityHuman
CH1 IsotypeIgG2
VD LCLambda
Highest_Clin_Trial (Jan '20)Approved
Est. StatusActive
100% SI StructureNone
99% SI StructureNone
95-98% SI StructureNone
Year Proposed2012
Year Recommended2013
CompaniesAmgen;Amgen Astellas BioPharma;University Hospital Inselspital
Conditions ApprovedCoronary disorders;Hypercholesterolaemia;Hyperlipoproteinaemia type IIa;Myocardial infarction;Stroke
Conditions ActiveHyperlipidaemia;Coronary artery disease;Dyslipidaemias
Conditions Discontinuedna
Development TechAbgenix XenoMouse